Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theo Rispens

Showing results (251-260 of 276) with videos related to

Pageof 28
Sort By:
Iscience|September 6, 2023
Comparative analysis of spike-specific IgG Fc glycoprofiles elicited by adenoviral, mRNA, and protein-based SARS-CoV-2 vaccinesJulie Van Coillie, Tamas Pongracz, Tonći Šuštić, et al.
European Journal of Immunology|January 8, 2026
SARS-CoV-2 mRNA Vaccination Leads to Transient Humoral and B Cell Bystander Responses in AdultsLisan H Kuijper, Laura Y L Kummer, Laura Fernandez Blanco, et al.
Science Advances|February 19, 2025
Deep profiling of B cells responding to various pathogens uncovers compartments in IgG memory B cell and antibody-secreting lineagesMathieu Claireaux, George Elias, Gius Kerster, et al.
RMD Open|August 4, 2025
TNF inhibitors affect the induction and maintenance of spike-specific B-cell responses after mRNA vaccinationLaura Yl Kummer, Lisan H Kuijper, Laura Fernández Blanco, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 31, 2020
Development of a SARS-CoV-2 Total Antibody Assay and the Dynamics of Antibody Response over Time in Hospitalized and Nonhospitalized Patients with COVID-19Erik H Vogelzang, Floris C Loeff, Ninotska I L Derksen, et al.
Ebiomedicine|February 26, 2025
Evolution of SARS-CoV-2 antibody repertoire after successive mRNA vaccinations under immunosuppressive treatmentJim B D Keijser, Eileen W Stalman, Luuk Wieske, et al.
Elife|July 15, 2022
Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273Niels J M Verstegen, Ruth R Hagen, Jet van den Dijssel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 4, 2024
Serum neurofilament light and glial fibrillary acidic protein levels are not associated with wearing-off symptoms in natalizumab-treated multiple sclerosis patientsAlyssa A Toorop, Mark Hj Wessels, Lynn Boonkamp, et al.
Allergy|March 5, 2024
Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after mRNA vaccinationAnika M Valk, Jim B D Keijser, Koos P J van Dam, et al.
Journal of Autoimmunity|February 22, 2024
mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8<sup>+</sup> T cell responsesJet van den Dijssel, Mariël C Duurland, Veronique Al Konijn, et al.
Pageof 28

Showing results (251-260 of 276) with videos related to

Sort By:
Pageof 28
Iscience|September 6, 2023
Comparative analysis of spike-specific IgG Fc glycoprofiles elicited by adenoviral, mRNA, and protein-based SARS-CoV-2 vaccinesJulie Van Coillie, Tamas Pongracz, Tonći Šuštić, et al.
European Journal of Immunology|January 8, 2026
SARS-CoV-2 mRNA Vaccination Leads to Transient Humoral and B Cell Bystander Responses in AdultsLisan H Kuijper, Laura Y L Kummer, Laura Fernandez Blanco, et al.
Science Advances|February 19, 2025
Deep profiling of B cells responding to various pathogens uncovers compartments in IgG memory B cell and antibody-secreting lineagesMathieu Claireaux, George Elias, Gius Kerster, et al.
RMD Open|August 4, 2025
TNF inhibitors affect the induction and maintenance of spike-specific B-cell responses after mRNA vaccinationLaura Yl Kummer, Lisan H Kuijper, Laura Fernández Blanco, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 31, 2020
Development of a SARS-CoV-2 Total Antibody Assay and the Dynamics of Antibody Response over Time in Hospitalized and Nonhospitalized Patients with COVID-19Erik H Vogelzang, Floris C Loeff, Ninotska I L Derksen, et al.
Ebiomedicine|February 26, 2025
Evolution of SARS-CoV-2 antibody repertoire after successive mRNA vaccinations under immunosuppressive treatmentJim B D Keijser, Eileen W Stalman, Luuk Wieske, et al.
Elife|July 15, 2022
Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273Niels J M Verstegen, Ruth R Hagen, Jet van den Dijssel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 4, 2024
Serum neurofilament light and glial fibrillary acidic protein levels are not associated with wearing-off symptoms in natalizumab-treated multiple sclerosis patientsAlyssa A Toorop, Mark Hj Wessels, Lynn Boonkamp, et al.
Allergy|March 5, 2024
Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after mRNA vaccinationAnika M Valk, Jim B D Keijser, Koos P J van Dam, et al.
Journal of Autoimmunity|February 22, 2024
mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8<sup>+</sup> T cell responsesJet van den Dijssel, Mariël C Duurland, Veronique Al Konijn, et al.
Pageof 28